Clinical Trial: Bioequivalence of a Generic Azilsartan Medoxomil Tablet Compared With the Reference Product (Edarbi(R)) in Healthy Chinese Volunteers Under Fasting and Fed Conditions

U.S., Oct. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07881263) titled 'Bioequivalence of a Generic Azilsartan Medoxomil Tablet Compared With the Reference Product (Edarbi(R)) in Healthy Chinese Volunteers Under Fasting and Fed Conditions' on Oct. 12.

Brief Summary: This study compared a test azilsartan medoxomil potassium tablet (80 mg) with the reference product, Edarbi(R) (80 mg), in healthy adults. The study included a fasting part and a part in which participants took the study medication after a meal. In each part, participants were randomly assigned to receive both products, one at a time, in a different order. There was a 5-day washout period between doses. Blood samples were collected before an...